|
This report has been identified as b.Braun internal report number (b)(4).Note: this report is being filed for an item number that is not sold in the united states, however similar items are sold in the united states by b.Braun medical, inc.Device history record (dhr): reviewed the device history record for batch number 24e12g8362 and there were no defect encountered during in process and final control inspection.Samples for evaluation: received 8 (eight) unused of introcan safety pur 22g, 0.9x25mm-eu and in original packaging.Lot number printed on returned peel pack are 24e12g8362 and material # 4251628-01.The actual reported complaint sample was not returned.Visual inspection: these samples were taken for investigation and observed the capillary does not exhibit any damages and no tear off capillaries.Complaint description: the situation described that a nurse reported catheter fragmentation after inspection with catheter removal due to extravasation.As communicated in ifu, warning section stated that: - do not re-use.Re-use of single-use devices creates a potential risk of patient or user.It may lead to contamination and/or impairment of functional capability.Contamination and/or limited functionality of the device may lead to injury, illness or death of the patient - in the case of an unsuccessful iv catheter placement attempt, remove the needle first to activate safety mechanism, then remove catheter from patient and discard both.Never reinsert the needle inside the catheter once the needle has been partially or completely withdrawn as it may pierce and/or sever the catheter.- extreme care should be taken not to damage, pierce, cut or sever the catheter.Therefore, do not bend the catheter and/or needle during insertion, advancement, or removal of the needle.- do not use scissors or sharp instruments at or near the insertion site.Reviewed assembly process: this product is assembled on automated assembly machines equipped with 100% vision system and test stations.The tear-off capillary defect is unlikely to have been caused by the manufacturing process because it can be detected by the vision system and be rejected automatically.The in-line test equipment is subject to frequent calibration and regular verification related to its proper function.Herewith potential malfunctions of the systems would be detected in-time and would be mitigated.The process cards for the complaint batch show no abnormality during the manufacturing process.Manufacturing control: besides the in-line test equipment, products are subjected to in-process and final control inspection based on random samples basis.Herewith, a systematic defect can be detected.The complaint batch shows the inspection result as passed.Conclusion: the returned samples found no defect or any abnormality.Complaint is not confirmed.
|